Your browser doesn't support javascript.
loading
A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies.
Li, Da; Pan, Hong; Wang, Wei; Xue, Yanan; Fang, Yong; Lou, Haizhou; Pan, Qin; Jin, Wei; Zheng, Yu; Han, Weidong; Zhu, Kongli; Zhao, Xianfeng; Xu, Rong; Han, Jin; Pan, Hongming.
Afiliação
  • Li D; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Wang W; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Xue Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Lou H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Pan Q; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Jin W; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Zheng Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Han W; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  • Zhu K; Shanghai Celfuture Biotech Co., Ltd., Shanghai, China.
  • Zhao X; Shanghai Celfuture Biotech Co., Ltd., Shanghai, China.
  • Xu R; Shanghai Celfuture Biotech Co., Ltd., Shanghai, China.
  • Han J; Shanghai Celfuture Biotech Co., Ltd., No. 280 Juli Rd. Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China.
  • Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, No. 3 East Qingchun Road, Hangzhou, Zhejiang 310016, China.
Ther Adv Med Oncol ; 15: 17588359231165968, 2023.
Article em En | MEDLINE | ID: mdl-37025261
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China